InsidersTradesSigma
基于 4 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Discover the detailed record of transactions filed by Ragard John Phillip. Director active across 1 company, notably Aspira Women's Health Inc.. In total, 5 reports have been logged. History available since 30 September 2024. The latest transaction was disclosed on 4 June 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Ragard John Phillip is a declarant linked to Aspira Women's Health Inc. (XNAS), where he is Director. He has 4 filings in total, and the sampled recent filings run from 2024-10-02 to 2025-04-01, with the modal transaction nature listed as option exercise; the buy and sell amounts in that sample are EUR 0 each.